On June 13th, Sunrise Group secured a global ranking of 6th place and 2nd place in the Asia-Pacific region on the latest ICIS Top 100 Chemical Companies list with sales revenue of US$4.5 billion.

ICIS Top 100 Chemical Companies list

In 2024, Sunrise Group strengthened its capabilities by adding a 42-acre production facility in a state-level pharmaceutical park and establishing an R&D center in Hangzhou—marking a significant stride in chemical manufacturing and innovation. The group's subsidiary, Zhejiang Sunrise Pharmaceutical, successfully renewed its EU GMP certification with a GOOD rating, while Taizhou Dachen Pharmaceutical advanced its Move-on-site collaboration with Bayer, driving operational efficiency and delivering greater value to customers.

Facing a complex and ever-changing market environment, Sunrise Group remains committed to market-driven strategies, continuously refining its operations and elevating service standards. In 2024, the company achieved sales revenue of $4.5 billion, marking an 8% year-on-year increase, while customer and product growth rates reached 20% and 10%, respectively. Notably, Sunrise Group's subsidiary, Zhejiang Sunrise Chemicals, was awarded the prestigious EcoVadis Platinum Medal for the first time—an internationally recognized certification that underscores the company's dedication to ESG (Environmental, Social, and Governance) excellence. This achievement reflects our proactive engagement in social responsibility, support for public welfare initiatives, and commitment to fostering sustainable development that benefits both business and society.

Asia Pacific Chemical Distribution leaders list

Moving forward, we will remain steadfast in our commitment to sustainable development, continuously enhancing our core competitiveness in chemical distribution. By strengthening collaboration with global partners, we aim to deliver superior products and services to our customers while driving progress in the global chemical industry.